CLASS II Device recall · Reported 2 Jun 2021 · FDA Enforcement Report

Pentax Medical Video Duodenoscope recalled by Pentax of America

Pentax of America is recalling Pentax Medical Video Duodenoscope, distributed nationwide in the US. The recall was initiated on 21 Apr 2021 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesAll units
Quantity recalled108 units

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number
Z-1682-2021
FDA event ID
87763
Recalling firm
Pentax of America, Montvale, NJ
Classification
Class II
Status
Terminated
Recall initiated
21 Apr 2021
FDA classified
25 May 2021
Reported
2 Jun 2021
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Other Reasons

Timeline

21 Apr 2021Recall initiated by company
25 May 2021Classified by FDA+34 days
2 Jun 2021Published in enforcement report+8 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

IFU updated: The warning section of the IFU for both the OE-A63 distal end cap and ED34-i10T2 duodenoscope has been updated to notify users of the associated risks with the distal end cap (OE-A63) unexpectedly becoming detached during a procedure and updated to notify users of what immediate actions should be taken in case the event occurs. This can result in unforseen events such as mucosal injury, lacerations, or bleeding of the patient. Detachment of the distal end cap (OE-A63) into the oral cavity of the patient may also result in aspiration

Product as listed by the FDA

Pentax Medical Video Duodenoscope - Product Usage: intended to be used with endoscopic devices and other ancillary equipment to provide optical visualization of (via a video monitor), and therapeutic access to, Biliary Tract via the Upper Gastrointestinal Tract, Model Number: ED34-i10T2.

Where it was distributed

US Nationwide distribution in the states of Alabama, California, Louisiana, Maryland, Michigan, Missouri, New Jersey, North Carolina, Pennsylvania, Texas, Washington, D.C.

Nationwide AlabamaCaliforniaDistrict of ColumbiaLouisianaMarylandMichiganMissouriNorth CarolinaNew JerseyPennsylvaniaTexas

Questions about this recall

Why was it recalled?

IFU updated: The warning section of the IFU for both the OE-A63 distal end cap and ED34-i10T2 duodenoscope has been updated to notify users of the associated risks with the distal end cap (OE-A63) unexpectedly becoming detached during a procedure and updated to notify users of what immediate actions should be taken in case the event occurs. This can result in unforseen events such as mucosal injury, lacerations, or bleeding of the patient. Detachment of the distal end cap (OE-A63) into the oral cavity of the patient may also result in aspiration

Which lots are affected?

All units

Where was it sold?

US Nationwide distribution in the states of Alabama, California, Louisiana, Maryland, Michigan, Missouri, New Jersey, North Carolina, Pennsylvania, Texas, Washington, D.C.

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Pentax of America

All 33

Other Surgical Instruments recalls

All 3,891